AUNP-12 Near-Infrared Fluorescence Probes across NIR-I to NIR-II Enable In Vivo Detection of PD-1/PD-L1 Axis in the Tumor Microenvironment
Bioconjugate Chemistry · 2024
DOI: 10.1021/acs.bioconjchem.4c00266 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioconjugate Chemistry, 2024. Verfasst von Xinyu Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical Colleg…. Hauptthemen laut MEDLINE: B7-H1 Antigen, Tumor Microenvironment, Fluorescent Dyes, Programmed Cell Death 1 Receptor. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Beijing Hospital Authority.
Abstract (Originalsprache)
The innovative PD-1/PD-L1 pathway strategy is gaining significant traction in cancer therapeutics. However, fluctuating response rates of 20-40% to PD-1/PD-L1 inhibitors, coupled with the risk of hyperprogression after immunotherapy, underscore the need for accurate patient selection and the identification of more beneficiaries. Molecular imaging, specifically near-infrared (NIR) fluorescence imaging, is a valuable alternative for real-time, noninvasive visualization of dynamic PD-L1 expression in vivo. This research introduces AUNP-12, a novel PD-L1-targeting peptide antagonist conjugated with Cy5.5 and CH1055 for first (NIR-I) and second near-infrared (NIR-II) imaging. These probes have proven to be effective in mapping PD-L1 expression across various mouse tumor models, offering insights into tumor-immune interactions. This study highlights the potential of AUNP-12-Cy5.5 and AUNP-12-CH1055 for guiding clinical immunotherapy through precise patient stratification and dynamic monitoring, supporting the shift toward molecular imaging for personalized cancer care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Radiology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, No. 1 Shuaifuyuan, Dongchen…
- Department of Cardiology, The Second Medical Center & National Clinical Research Center for Geriatric Diseases, Chinese People's Liberation Army (PLA) General Hospital, 28 Fuxing Road, Haidian District, Beijing 100853,…
- University of Science and Technology of China, 96 Jinzhai Road, Hefei 230026, China.
- Engineering Research Center of Molecular and Neuro Imaging of Ministry of Education, School of Life Science and Technology, Xidian University, Xi'an 710126, China.
ORCID-Profile: Huadan Xue
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Beijing Hospital Authority
- National High Level Hospital Clinical Research Funding
- Shaanxi Fundamental Science Research Project for Chemistry and Biology
- Key Research and Development Program of Xianyang
Zitieren
APA
Zhang, X., Wang, P., Shi, G., Tang, C., & Xue, H. (2024). AUNP-12 Near-Infrared Fluorescence Probes across NIR-I to NIR-II Enable In Vivo Detection of PD-1/PD-L1 Axis in the Tumor Microenvironment. Bioconjugate Chemistry. https://doi.org/10.1021/acs.bioconjchem.4c00266
Vancouver
Zhang X, Wang P, Shi G, Tang C, Xue H. AUNP-12 Near-Infrared Fluorescence Probes across NIR-I to NIR-II Enable In Vivo Detection of PD-1/PD-L1 Axis in the Tumor Microenvironment. Bioconjugate Chemistry. 2024. doi:10.1021/acs.bioconjchem.4c00266
BibTeX
@article{Zhang2024,
author = {Zhang, Xinyu and Wang, Ping and Shi, Guangyuan and Tang, Chu and Xue, Huadan},
title = {AUNP-12 Near-Infrared Fluorescence Probes across NIR-I to NIR-II Enable In Vivo Detection of PD-1/PD-L1 Axis in the Tumor Microenvironment},
journal = {Bioconjugate Chemistry},
year = {2024},
doi = {10.1021/acs.bioconjchem.4c00266}
}
EUVIMED